Continental Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-46,376
Closed -$1.49M – 154
2016
Q3
$1.49M Buy
+46,376
New +$1.55M 0.42% 73

Other funds holding PFE

Continental Advisors's PFE Position: Q3 2026 in Review

Continental Advisors reduced its Pfizer (PFE) stake by 1.1% in Q3 2026, selling an estimated $120K and leaving 410,938 shares worth $11.7M. The position accounts for 5.02% of the portfolio, ranked #3.

Continental Advisors first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Continental Advisors held 410,938 shares of Pfizer worth $11.7M as of Q3 2026.
  • Continental Advisors sold 4,500 Pfizer shares in Q3 2026, an estimated $120K.
  • Pfizer made up 5.02% of Continental Advisors's portfolio in Q3 2026, its #3 holding.
  • Continental Advisors first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Continental Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.